VTGN
VistaGen Therapeutics Inc
NASDAQ: VTGN · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.94% today
Updated 2026-04-30
Market cap
$23.64M
P/E ratio
—
P/S ratio
29.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $5
Volume
0.7M
VistaGen Therapeutics Inc (VTGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |